Sara M Tolaney
Affiliation: Massachusetts General Hospital
- Follow-up care of patients with breast cancerSara M Tolaney
Dana Farber Cancer Institute, 44 Binney Street, Mayer 2, Boston, MA 02115, USA
Breast 16:S45-50. 2007..With the growing number of breast cancer survivors, further studies should be undertaken to study the cost-effectiveness of surveillance strategies...
- Sarcoidosis mimicking metastatic breast cancerSara M Tolaney
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Clin Breast Cancer 7:804-10. 2007..We describe 3 patients who presented with locally advanced breast cancer and who were found to have pulmonary findings for metastatic disease that were proven upon biopsy to be consistent with sarcoidosis...
- Lymphopenia associated with adjuvant anthracycline/ taxane regimensSara M Tolaney
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Clin Breast Cancer 8:352-6. 2008....
- Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancerSara M Tolaney
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
J Clin Oncol 24:5330-1. 2006
- Mechanisms of trastuzumab resistance in breast cancerSara M Tolaney
Dana Farber Cancer Institute, Boston, MA 02115, USA
Anticancer Agents Med Chem 9:348-55. 2009..In this review, we discuss the mechanisms of antitumor activity of trastuzumab, potential mechanisms contributing to its resistance, and novel therapeutic agents that may provide a means to overcome trastuzumab resistance...
- Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancerJudy E Garber
Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
J Natl Cancer Inst 102:942-9. 2010..We investigated whether FVL was associated with TE risk in women with early-stage breast cancer who took adjuvant tamoxifen...